Bispecific Antibody Therapeutic Market
Bispecific Antibody Therapeutic Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Bispecific Antibody Therapeutic Market Size and Growth
The Bispecific Antibody Therapeutic market is experiencing robust growth, driven by advancements in immunotherapy and increasing prevalence of cancers and autoimmune diseases. The market is projected to reach approximately $10 billion by 2027, highlighting significant investment opportunities and a trend towards innovative therapeutic solutions in the pharmaceutical industry. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Creative-biolabs
◍ PharmAbcine
◍ Sorrento Therapeutics
◍ Patheon
The bispecific antibody therapeutic market features companies like Creative-Biolabs for custom antibody development, PharmAbcine focusing on immunooncology, Sorrento Therapeutics with diverse applications in cancer therapies, and Patheon offering manufacturing solutions. Their innovations and collaborations drive market growth, enhancing treatment options for complex diseases, thus expanding commercial opportunities.
Sales Revenues:
- Sorrento Therapeutics: Approximately $39 million
- Creative-Biolabs: Estimated in the multi-million range
- Patheon (part of Thermo Fisher): Revenue over $12 billion (pharma services)
Request Sample Report
Market Segmentation
By Application
By Product
Lacking An Fc Region ◍ Osteology ◍ Pulmonary ◍ Respiratory Diseases ◍ Oncology
Gene Therapy
◍ Bearing An Fc Region
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
